HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer

Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer;   Endometrial Cancer Intervention:   Drug: HS-20089 Sponsor:   Hansoh BioMedical R&D  Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials